天臣医疗（688013）8月21日主力资金净卖出1024.65万元

Core Viewpoint - Tianchen Medical (688013) has shown a positive stock performance with a closing price of 41.25 yuan on August 21, 2025, reflecting a 3.44% increase, despite a net outflow of main funds [1][2]. Group 1: Stock Performance and Trading Data - On August 21, 2025, Tianchen Medical's stock price increased by 3.44% with a trading volume of 22,200 hands and a total transaction amount of 89.30 million yuan [1]. - The main funds experienced a net outflow of 10.25 million yuan, accounting for 11.47% of the total transaction amount, while retail investors saw a net inflow of 5.84 million yuan, representing 6.54% of the total [1][2]. - Over the past five days, the stock has fluctuated, with the highest closing price being 41.25 yuan and the lowest at 39.04 yuan [2]. Group 2: Financing and Margin Trading Data - As of August 21, 2025, the financing balance for Tianchen Medical was 106 million yuan, with a net financing purchase of 1.42 million yuan [3]. - The company had no short-selling activity, with a margin trading balance remaining at 106 million yuan [3]. Group 3: Company Financials and Industry Comparison - Tianchen Medical reported a main revenue of 65.84 million yuan for Q1 2025, a year-on-year increase of 9.34%, and a net profit of 13.19 million yuan, up 16.16% year-on-year [5]. - The company has a total market value of 3.348 billion yuan, which is significantly lower than the industry average of 12.244 billion yuan [5]. - Key financial metrics include a price-to-earnings ratio of 63.47, a price-to-book ratio of 6.3, and a gross margin of 58.46%, all of which indicate a competitive position within the medical device industry [5].